BMRN vs RSSS · P/E 40, rev $2.85B vs P/E 15, rev $49.1M
Biomarin Pharmaceutical Inc (BMRN) versus Research Solutions Inc (RSSS) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Research Solutions Inc (RSSS) is a software - application company listed on NASDAQ.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported RSSS revenue for 2025-06-30 was $49.1M. Net income was $1.3M. Revenue was up 9.9% from 2024-06-30 to 2025-06-30. RSSS currently screens at market cap $74.9M and trailing P/E 14.9.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. RSSS currently screens at market cap $74.9M and trailing P/E 14.9.
Not investment advice. Open the BMRN and RSSS stock pages for the full models.
Not investment advice.